2-(2-Amino-5-Bromobenzoyl)pyridine CAS 1563-56-0 Purity >99.0% (HPLC) Factory

Short Description:

2-(2-Amino-5-Bromobenzoyl)pyridine 

CAS: 1563-56-0

Purity: >99.0% (HPLC)

Appearance: Yellow Crystalline Powder  

Intermediate of Remimazolam & Bromazepam

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

1563-56-0 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 2-(2-Amino-5-Bromobenzoyl)pyridine (CAS: 1563-56-0) with high quality, intermediate of Remimazolam & Bromazepam. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Remimazolam Intermediates, Please contact: alvin@ruifuchem.com

Remimazolam Intermediates:

1563-56-0 - Chemical Properties:

Chemical Name 2-(2-Amino-5-Bromobenzoyl)pyridine 
Synonyms 2-Amino-5-Bromobenzoylpyridine; 4-Bromo-2-[(Pyridin-2-yl)carbonyl]aniline; (2-Amino-5-Bromophenyl)(Pyridin-2-yl)methanone; 2-Amino-5-Bromophenyl 2-Pyridyl Ketone; 2-Amino-5-Bromophenyl-2-Pyridylmethanone
Impurity Bromazepam EP impurity A
Stock Status In Stock, Commercial Production  
CAS Number 1563-56-0
Molecular Formula C12H9BrN2O
Molecular Weight 277.12 g/mol
Melting Point 97.0~101.0℃ 
Boiling Point 451℃
Flash Point 227℃
Density 1.546 
Refractive Index n20/D 1.658
COA & MSDS Available
Origin of Product    Shanghai, China
Product Categories
Pharmaceutical Intermediates
Brand Ruifu Chemical

1563-56-0 - Specifications:

Items Specifications  Results
Appearance Yellow Crystalline Powder  Yellow Crystalline Powder 
Melting Point 97.0~101.0℃ 97.3~98.3℃
Loss on Drying <0.50% 0.17%
Purity / Analysis Method >99.0% (HPLC Area)  99.7%
1H NMR Spectrum Conforms to Structure  Conforms 
Conclusion The product has been tested and complies with the given specifications
Application Intermediate of Remimazolam & Bromazepam

1563-56-0 - Method of Analysis:

(1), Product Specifications
Properties: This product is yellow crystalline powder
Melting Point: 97.0~101.0℃
Loss on Drying: <0.50%
Purity Determination: This product is calculated on the dry basis, the purity shall not be less than 99.0%
(2), Method of Analysis
1. Properties: This product is yellow crystalline powder (visual)
2. Melting point: The melting point of this product (Chinese Pharmacopoeia 2005 Appendix VI C) is 97.0~101.0℃; The heating rate is 1.5℃/ min
3. Loss on Drying: Take 1g of this product, dry it at 80℃ for 4 hours, and the weight loss shall not exceed 0.50% (Chinese Pharmacopoeia 2005 Appendix VIII L)
4. Take the appropriate amount of this product, prepare 0.5mg/ml solution with flow matching, the sample size is 5μL, determine according to high performance liquid chromatography (Chinese Pharmacopoeia 2005 Appendix V D), calculate by area normalization method, and obtain.
5. Chromatographic Conditions (HPLC)
Instrument Model: Shimadzu
Column Type: C18 250*4.6mm
Mobile Phase: Methanol: 0.1% phosphoric acid aqueous solution (triethylamine adjusted pH value=3.4)=7:3
Sensitivity: 0.02 AUFA
Wavelength: 240nm
Flow Rate: 1.0ml/min
Column Temperature: 40℃
Retention Time: 30min

1563-56-0 - Package/Storage/Shipping:

Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry, well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

1563-56-0 - Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

1563-56-0 - FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

1563-56-0 - Application:

2-(2-Amino-5-Bromobenzoyl)pyridine (CAS: 1563-56-0) is an intermediate of Remimazolam and Bromazepam. 

Remimazolam, also known as CNS-7056, is a benzodiazepine derivative drug, developed by PAION, in collaboration with Japanese licensee Ono Pharmaceutical as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.

  • Write your message here and send it to us